Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Arcus Biosciences, Inc. Transaction History
Commonwealth Of Pennsylvania Public School Empls Retrmt Sys
- $15.5 Billion
- Q3 2024
A detailed history of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Commonwealth Of Pennsylvania Public School Empls Retrmt Sys holds 11,530 shares of RCUS stock, worth $163,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,530
Previous 11,759
1.95%
Holding current value
$163,726
Previous $179,000
1.68%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RCUS
# of Institutions
200Shares Held
51.5MCall Options Held
236KPut Options Held
141K-
Black Rock Inc. New York, NY9.76MShares$139 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.47MShares$77.7 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.48MShares$49.4 Million0.48% of portfolio
-
State Street Corp Boston, MA3.01MShares$42.8 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.44MShares$34.6 Million0.1% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.02B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...